Randomized-controlled trials are methodologically inappropriate in adolescent transgender healthcare

F Ashley, DM Tordoff, J Olson-Kennedy… - International Journal of …, 2023 - Taylor & Francis
Background Despite multiple rigorous observational studies documenting the association
between positive mental health outcomes and access to puberty blockers, hormone therapy …

Pediatric drug development: reviewing challenges and opportunities by tracking innovative therapies

C Domingues, I Jarak, F Veiga, M Dourado, A Figueiras - Pharmaceutics, 2023 - mdpi.com
The paradigm of pediatric drug development has been evolving in a “carrot-and-stick”-based
tactic to address population-specific issues. However, the off-label prescription of adult …

The Cass Review: Cis-supremacy in the UK's approach to healthcare for trans children

C Horton - International Journal of Transgender Health, 2024 - Taylor & Francis
Background Since 2016 trans people in the UK, and particularly trans children, have
experienced a sustained and escalating campaign to roll back trans freedoms, rights and …

Off-Label Prescribing in Pediatric Population—Literature Review for 2012–2022

V Petkova, D Georgieva, M Dimitrov, I Nikolova - Pharmaceutics, 2023 - mdpi.com
Off-label prescribing is widespread among pediatricians, and it is unlikely that this trend will
soon be bound by a uniform legal framework. This is necessitated by the fact that there are …

Two Years of Active Pharmacovigilance Surveillance and Therapeutic Reconciliation in Frail Populations: The MEAP 3.0 Study

A Bombelli, G Guarnieri, N Lombardi, MG Sullo… - Journal of Clinical …, 2023 - mdpi.com
Awareness related to the risk/benefit profile of therapies used in paediatric and elderly
patients is limited. We carried out a study, called the MEAP 3.0 study, to collect and analyse …

Pediatric drug and other shortages in the age of supply chain disruption

C Shachar, PA Gruppuso, EY Adashi - Jama, 2023 - jamanetwork.com
The last year witnessed several significant shortages of key medicines and other products
for children, including children's formulations of acetaminophen and ibuprofen as well as …

[HTML][HTML] A Complex Intervention to Prevent Medication-Related Hospital Admissions: Results of the Stepped-wedge Cluster Randomized Trial KiDSafe in Pediatrics

A Neubert, I Toni, J König, MS Urschitz… - Deutsches Ärzteblatt …, 2023 - ncbi.nlm.nih.gov
Background Children are often treated off-label and are at a disadvantage in
pharmacotherapy. The aim of this study was to implement and evaluate a quality assurance …

Off-label and unlicenced medicine use among hospitalised children in South Africa: practice and policy implications

H Mathevula, N Schellack, S Orubu, B Godman… - Pharmacy, 2023 - mdpi.com
Background: Information regarding off-label and unlicensed medicine use among South
African children is limited. This is a concern as the prescribing of off-label and unlicensed …

Perceptions and experiences of community pharmacists with off-label prescribing in the pediatric population

F Noga, E Hoti, E Ibrahimi, D Toma… - International Journal of …, 2024 - academic.oup.com
Objectives This study aimed to investigate and provide insight into the prevalence and
patterns of off-label drug use in the pediatric population from the perspective of community …

[HTML][HTML] Navigating Pediatric Capnography: A Comprehensive Review of Scope and Limitations

SH Damam, RJ Meshram, A Taksande, S Lohiya… - Cureus, 2024 - ncbi.nlm.nih.gov
This review comprehensively explores pediatric capnography, a vital tool in contemporary
respiratory monitoring. The overview encompasses the foundational principles of …